LG Life Sciences conclude joint sales agreement of Micera with Roche Korea

Published: 2016-07-13 16:20:46

Updated: 2016-07-13 16:20:46

On the 11^th, LG Life Sciences(CEO Il-jae Jung) and Roche Korea(CEO Matt Sause) announced conclusion of the joint sales agreement of Mircera, a anemia treatment for chronic kidney disease patients. Micera is a product to treat anemia in people with chronic kidney disease.

According to the company, Micera Prefilled Syringe has a longer half-life(approximately 134 hours) than existing products, ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.